Not applicableUnknownNCT02666755What this trial is testingNovel Detection System for Lung Cancer Curative Effect MonitoringWho this might be right forLung Neoplasms Jian Zhang 160
Testing effectiveness (Phase 2)Study completedNCT00580333What this trial is testingPreoperative Cisplatin and Bevacizumab in ER-, PR-, HER2 Negative Breast CancerWho this might be right forBreast Cancer Massachusetts General Hospital 51
Not applicableStudy completedNCT02695849What this trial is testingPrevalence of EGFR Mutations in Participants With NSCLCWho this might be right forNon-Small Cell Lung Cancer Hoffmann-La Roche 69
Testing effectiveness (Phase 2)Looking for participantsNCT05271916What this trial is testingFirst-line Treatment With Dacomitinib Plus Anlotinib for Patients With Advanced NSCLC With EGFR 21L858R MutationsWho this might be right forNon-Small Cell Lung Cancer (NSCLC) Shanghai Chest Hospital 140
Not applicableStudy completedNCT02108769What this trial is testingYogic Breathing Changes Salivary ComponentsWho this might be right forAlzheimer DiseaseNeurodegenerative DiseasesCancer Medical University of South Carolina 20
Early research (Phase 1)Study completedNCT00721266What this trial is testingA Dose-Escalation Study of RO5083945 in Patients With Metastatic and/or Locally Advanced Malignant Epidermal Growth Factor Receptor (EGFR)+ Solid Tumors.Who this might be right forNeoplasms Hoffmann-La Roche 102
Testing effectiveness (Phase 2)Ended earlyNCT06851442What this trial is testingClinical Trial of Evaluating TQB3912 Tablets Combined With Fulvestrant Injection±TQB3616 Capsules for Locally Advanced or Metastatic Hormone Receptor(HR)-Positive and Human Epidermal Growth Factor Receptor 2 (HER2)-Negative Breast CancerWho this might be right forBreast Cancer Chia Tai Tianqing Pharmaceutical Group Co., Ltd. 8
Large-scale testing (Phase 3)Study completedNCT02864251What this trial is testingNivolumab + Chemotherapy or Nivolumab + Ipilimumab Versus Chemotherapy in Non-Small Cell Lung Cancer (NSCLC) Participants With Epidermal Growth Factor Receptor (EGFR) Mutation Who Failed 1L or 2L EGFR Tyrosine Kinase Inhibitor (TKI) TherapyWho this might be right forNon-Small-Cell Lung Carcinoma Bristol-Myers Squibb 367
Early research (Phase 1)Study completedNCT00882674What this trial is testingEvaluate the Biological Activity of R1507 in Women With Operable Breast CancerWho this might be right forBreast Cancer Hoffmann-La Roche 8
Testing effectiveness (Phase 2)Study completedNCT01532089What this trial is testingErlotinib Hydrochloride With or Without Bevacizumab in Treating Patients With Stage IV Non-small Cell Lung Cancer With Epidermal Growth Factor Receptor MutationsWho this might be right forEGFR Exon 19 Deletion MutationEGFR NP_005219.2:p.L858RLung Non-Squamous Non-Small Cell Carcinoma+1 more Academic and Community Cancer Research United 88
Testing effectiveness (Phase 2)UnknownNCT05019794What this trial is testingInfigratinib in Subjects With GC or GEJ With FGFR2 Amplification or Other Solid Tumors With Other FGFR AlterationsWho this might be right forGastric CancerGastroesophageal Junction AdenocarcinomaSolid Tumor LianBio LLC 80
Large-scale testing (Phase 3)Active Not RecruitingNCT06018337What this trial is testingDB-1303/BNT323 vs Investigator's Choice Chemotherapy in HER2-Low, Hormone Receptor Positive Metastatic Breast Cancer (DYNASTY-Breast02)Who this might be right forMetastatic Breast Cancer DualityBio Inc. 541
Not applicableUnknownNCT01376583What this trial is testingExercise Controls Tumor Cell Growth Through AMPK ActivationWho this might be right forBreast Cancer Rigshospitalet, Denmark 10
Not applicableEnded earlyNCT02823262What this trial is testingA Breast Cancer Treatment Decision Aid for Women Aged 70 and OlderWho this might be right forBreast CancerEstrogen Receptor Positive Breast CancerNode-negative Breast Cancer+1 more Beth Israel Deaconess Medical Center 65
Large-scale testing (Phase 3)Not Yet RecruitingNCT07754123What this trial is testingPhase III Study of HS-10504 Versus Platinum-Based Doublet Chemotherapy in Patients With C797S+ NSCLCWho this might be right forAdvanced or Metastatic NSCLC Jiangsu Hansoh Pharmaceutical Co., Ltd. 206
Testing effectiveness (Phase 2)Looking for participantsNCT07796880What this trial is testingNeoadjuvant Culmerciclib Combined With Endocrine Therapy for Hormone Receptor-Positive， Human Epidermal Growth Factor Receptor 2-Negative Breast CancerWho this might be right forHormone Receptor-Positive Breast CancerHER2 Low Breast CarcinomaEarly-Stage Breast Cancer Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University 80
Testing effectiveness (Phase 2)Study completedNCT00109941What this trial is testingOpioid Growth Factor in Treating Patients With Advanced Pancreatic Cancer That Cannot Be Removed By SurgeryWho this might be right forPancreatic Cancer Milton S. Hershey Medical Center 25
Early research (Phase 1)Study completedNCT00702494What this trial is testingPhase I Study on Monoclonal Antibody TB-403 Directed Against PlGF in Patients With Solid TumoursWho this might be right forSolid Tumors BioInvent International AB 21
Not applicableStudy completedNCT00970970What this trial is testingVisualizing Vascular Endothelial Growth Factor (VEGF) Producing Lesions in Von Hippel-Lindau DiseaseWho this might be right forVon Hippel-Lindau DiseaseHemangioblastomaRenal Cell Carcinoma+2 more University Medical Center Groningen 22
Early research (Phase 1)UnknownNCT04363242What this trial is testingFind the MTD of SYN125 in People With Solid Tumors and the MTD of SYN125 With a Fixed Dose of SYN004 in People in Patients With Epithelial Cancers With EGFR ExpressionsWho this might be right forEpithelial CarcinomaSolid Tumor Synermore Biologics Co., Ltd. 22